|
Q2 FY2027
As of Jul 4, 2026
|
Q1 FY2027
As of Apr 4, 2026
|
Q4 FY2026
As of Jan 3, 2026
|
Q3 FY2026
As of Sep 27, 2025
|
Q2 FY2026
As of Jun 28, 2025
|
Q1 FY2026
As of Mar 29, 2025
|
Q4 FY2025
As of Dec 28, 2024
|
Q3 FY2025
As of Sep 28, 2024
|
Q2 FY2025
As of Jun 29, 2024
|
Q1 FY2025
As of Mar 30, 2024
|
Q4 FY2024
As of Dec 30, 2023
|
Q3 FY2024
As of Sep 30, 2023
|
Q2 FY2024
As of Jul 1, 2023
|
Q1 FY2024
As of Apr 1, 2023
|
Q4 FY2023
As of Dec 31, 2022
|
Q3 FY2023
As of Oct 1, 2022
|
Q2 FY2023
As of Jul 2, 2022
|
Q1 FY2023
As of Apr 2, 2022
|
Q4 FY2022
As of Jan 1, 2022
|
Q3 FY2022
As of Oct 2, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Patient accounts receivable | ||||||||||||||||||||
| Receivables under insured programs | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right of use assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Receivables under insured programs | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and other accrued liabilities | ||||||||||||||||||||
| Accrued payroll and employee benefits | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Current portion of insurance reserves - insured programs | ||||||||||||||||||||
| Current portion of insurance reserves | ||||||||||||||||||||
| Securitization obligations | ||||||||||||||||||||
| Current portion of long-term obligations | ||||||||||||||||||||
| Current portion of operating lease liabilities | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term obligations, less current portion | ||||||||||||||||||||
| Long-term insurance reserves - insured programs | ||||||||||||||||||||
| Long-term insurance reserves | ||||||||||||||||||||
| Operating lease liabilities, less current portion | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Deferred restricted stock units | ||||||||||||||||||||
| Stockholders' equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value as of July 4, 2026 and January 3, 2026 5,000,000 shares authorized; none issued or outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value, 1,000,000,000 shares authorized; 217,510,046 and 210,996,359 issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities, deferred restricted stock units, and stockholders' equity | ||||||||||||||||||||
Loading...
